the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title Study of SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer
Official Title A Phase 1a/1b Dose Escalation and Expansion Study of Single-Agent SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer
Principal Investigator Fleming, Gini
Brief Summary This is a Phase 1a/1b study of SC-003 in patients with platinum-resistant/refractory ovarian cancer. SC-003 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody linked to a potent chemotherapy.
Gender Female
Ages 18 Years
Enrollment 108
Accepts Healthy Volunteers No
Lead Sponsor StemcentrxIndustry
Collaborator
Study Design
Study Phase Phase 1
Study Type Interventional
Contact Name
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Ovarian Cancer
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI